Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|3|930-941

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.3, 2015-03, pp. : 930-941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When good transforming growth factor‐β turns bad in hepatocellular carcinoma: Axl takes the stage

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 759-761

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetic inactivation of transforming growth factor‐β1 target gene HEYL, a novel tumor suppressor, is involved in the P53‐induced apoptotic pathway in hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 782-793

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor‐β and psoriasis: a new link

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1480-1481

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition airway remodeling and transforming growth factor-β1/Smad signaling pathway by astragalus extract in asthmatic mice

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-01 ,pp. : 564-568

Spandidos Publications

Access to resources Recommend Favorite

Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo

By                

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 499-506

Spandidos Publications

Access to resources Recommend Favorite